Coya Therapeutics, Inc. (COYA)
Coya Therapeutics, Inc. (COYA) Insider Trading
Directors, officers and holders of more than 10% of COYA report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 30 most recent of 30 transactions on file: 4 with code P, 0 with code S and 26 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 9, 2026 | Pavao Mark H | Director | A Award | 10,000 | Not measured | Not measured |
| Jan 22, 2026 | Berman Howard | Executive Chairman | A Award | 15,257 | Not measured | Not measured |
| Jan 22, 2026 | Grossman Fred | Chief Medical Officer | A Award | 140,041 | Not measured | Not measured |
| Jan 22, 2026 | SNYDER DAVID S | Chief Financial Officer | A Award | 140,041 | Not measured | Not measured |
| Jan 22, 2026 | Swaminathan Arun | Chief Executive Officer | A Award | 293,983 | Not measured | Not measured |
| Jan 2, 2026 | Lee Ann | Director | A Award | 10,000 | Not measured | Not measured |
| Jan 2, 2026 | Villalobos Anabella | Director | A Award | 10,000 | Not measured | Not measured |
| Jan 2, 2026 | GOLDSTEIN DOV A MD | Director | A Award | 10,000 | Not measured | Not measured |
| Jan 2, 2026 | Weinand Dieter | Director | A Award | 10,000 | Not measured | Not measured |
| Jan 2, 2026 | ROSS WILBUR L JR | Director | A Award | 10,000 | Not measured | Not measured |
| Aug 18, 2025 | GOLDSTEIN DOV A MD | Director | M Exercise | 17,557 | $1.09 | $19,137 |
| Aug 18, 2025 | GOLDSTEIN DOV A MD | Director | M Exercise | 17,557 | Not measured | Not measured |
| Feb 25, 2025 | Lee Ann | Director | A Award | 5,000 | Not measured | Not measured |
| Feb 25, 2025 | Villalobos Anabella | Director | A Award | 5,000 | Not measured | Not measured |
| Feb 25, 2025 | GOLDSTEIN DOV A MD | Director | A Award | 5,000 | Not measured | Not measured |
| Feb 25, 2025 | Weinand Dieter | Director | A Award | 5,000 | Not measured | Not measured |
| Feb 25, 2025 | ROSS WILBUR L JR | Director | A Award | 5,000 | Not measured | Not measured |
| Jan 9, 2025 | SNYDER DAVID S | Chief Financial Officer | A Award | 140,562 | Not measured | Not measured |
| Jan 9, 2025 | Swaminathan Arun | Chief Executive Officer | A Award | 240,964 | Not measured | Not measured |
| Jan 9, 2025 | Grossman Fred | Chief Medical Officer | A Award | 140,562 | Not measured | Not measured |
| Jan 9, 2025 | Berman Howard | Executive Chairman | A Award | 150,602 | Not measured | Not measured |
| Jan 1, 2025 | GOLDSTEIN DOV A MD | Director | A Award | 5,000 | Not measured | Not measured |
| Jan 1, 2025 | ROSS WILBUR L JR | Director | A Award | 5,000 | Not measured | Not measured |
| Jan 1, 2025 | Lee Ann | Director | A Award | 5,000 | Not measured | Not measured |
| Jan 1, 2025 | Villalobos Anabella | Director | A Award | 5,000 | Not measured | Not measured |
| Jan 1, 2025 | Weinand Dieter | Director | A Award | 5,000 | Not measured | Not measured |
| Nov 14, 2024 | SNYDER DAVID S | Chief Financial Officer | P Purchase | 1,800 | $7.19 | $12,934 |
| Nov 13, 2024 | Swaminathan Arun | Chief Executive Officer | P Purchase | 5,000 | $7.36 | $36,797 |
| Nov 11, 2024 | Swaminathan Arun | Chief Executive Officer | P Purchase | 5,000 | $7.34 | $36,689 |
| Nov 11, 2024 | Grossman Fred | Chief Medical Officer | P Purchase | 2,710 | $7.37 | $19,973 |
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.